Technologies in the Treatment of Bone Marrow Edema Syndrome

Reza A Ghasemi; Saleh Sadeghi; Narges Rahimee; Mohamadnaghi Tahmasebi

doi:10.1016/j.ocl.2018.08.008

Technologies in the Treatment of Bone Marrow Edema Syndrome

Orthop Clin North Am. 2019 Jan;50(1):131-138. doi: 10.1016/j.ocl.2018.08.008.

Authors

Reza A Ghasemi¹, Saleh Sadeghi², Narges Rahimee², Mohamadnaghi Tahmasebi²

Affiliations

¹ Tehran University of Medical Science, Number 21, Dameshgh Street, Vali-e Asr Avenue, Tehran 1416753955, Iran. Electronic address: ghasemiar2@gmail.com.
² Tehran University of Medical Science, Number 21, Dameshgh Street, Vali-e Asr Avenue, Tehran 1416753955, Iran.

PMID: 30477703
DOI: 10.1016/j.ocl.2018.08.008

Abstract

Bone marrow edema syndrome is a rare and self-limited syndrome with an unknown cause. The natural time course for improvement of clinical symptoms and normalization in MRI lasts from 3 to 18 months. This entity must be distinguished from other causes of marrow abnormality, such as stress fractures and osteonecrosis, for the best treatment options. Various treatments from conservative to surgical have been made to provide pain relief and accelerate the natural course of the disease. This article reviews bone marrow edema syndrome with a focus on treatment in the foot and ankle.

Keywords: BMES; Bisphosphonate; Core decompression; Iloprost; Transient osteoporosis.

Publication types

Review

MeSH terms

Bone Marrow / diagnostic imaging*
Bone Marrow Diseases / diagnosis
Bone Marrow Diseases / therapy*
Edema / diagnosis
Edema / therapy*
Humans
Magnetic Resonance Imaging / methods*
Orthopedic Procedures / methods*
Syndrome